Batiuk TD - Search Results

1

Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral.

Mendez R, Abboud H, Burdick J, Copley B, Freeman R, Batiuk TD, Cooney GF, Barbeito R. Mendez R, et al. Among authors: batiuk td. Clin Ther. 1999 Jan;21(1):160-71. doi: 10.1016/S0149-2918(00)88276-4. Clin Ther. 1999. PMID: 10090433 Clinical Trial.

2

Calcineurin activity in children with renal transplants receiving cyclosporine.

Quien RM, Kaiser BA, Dunn SP, Kulinsky A, Polinsky M, Baluarte HJ, Batiuk TD, Halloran PF. Quien RM, et al. Among authors: batiuk td. Transplantation. 1997 Nov 27;64(10):1486-9. doi: 10.1097/00007890-199711270-00022. Transplantation. 1997. PMID: 9392319

3

Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.

Batiuk TD, Barry JM, Bennett WM, Meyer MM, Tolzman D, Norman DJ. Batiuk TD, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1391. Transplant Proc. 1993. PMID: 8382860 Clinical Trial. No abstract available.

4

Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible.

Batiuk TD, Pazderka F, Enns J, DeCastro L, Halloran PF. Batiuk TD, et al. J Clin Invest. 1995 Sep;96(3):1254-60. doi: 10.1172/JCI118159. J Clin Invest. 1995. PMID: 7657799 Free PMC article.

5

Cyclosporine-treated renal transplant patients have only partial inhibition of calcineurin phosphatase activity.

Batiuk TD, Pazderka F, Halloran PF. Batiuk TD, et al. Transplant Proc. 1995 Feb;27(1):840-1. Transplant Proc. 1995. PMID: 7879200 Clinical Trial. No abstract available.

6

A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantation.

Norman DJ, Kimball JA, Bennett WM, Shihab F, Batiuk TD, Meyer MM, Barry JM. Norman DJ, et al. Among authors: batiuk td. Transpl Int. 1994 Aug;7(5):356-61. doi: 10.1007/BF00336712. Transpl Int. 1994. PMID: 7993573 Clinical Trial.

7

Cytokine nephropathy during antilymphocyte therapy.

Batiuk TD, Bennett WM, Norman DJ. Batiuk TD, et al. Transplant Proc. 1993 Apr;25(2 Suppl 1):27-30. Transplant Proc. 1993. PMID: 8465418 No abstract available.

8

Early Post-transplant Lymphoproliferative Disease in the Donor Ureter Without Systemic Involvement: A Case Report.

Bennett WM, Batiuk TD, McEvoy KM, Douzdjian V, Hyde J, Shaut C, Segal GM. Bennett WM, et al. Among authors: batiuk td. Transplant Proc. 2015 Sep;47(7):2301-3. doi: 10.1016/j.transproceed.2015.07.005. Transplant Proc. 2015. PMID: 26361705

9

Renal Cell Carcinoma in Renal Transplantation: The Case for Surveillance.

Bennett WM, Simonich EL, Garre AM, McEvoy KM, Farinola MA, Batiuk TD. Bennett WM, et al. Among authors: batiuk td. Transplant Proc. 2017 Oct;49(8):1779-1782. doi: 10.1016/j.transproceed.2017.06.031. Transplant Proc. 2017. PMID: 28923624

10

Enteric oxalate nephropathy in the renal allograft: an underrecognized complication of bariatric surgery.

Troxell ML, Houghton DC, Hawkey M, Batiuk TD, Bennett WM. Troxell ML, et al. Among authors: batiuk td. Am J Transplant. 2013 Feb;13(2):501-9. doi: 10.1111/ajt.12029. Epub 2013 Jan 11. Am J Transplant. 2013. PMID: 23311979 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters